Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0000711377-10-000039)

Filing Details

Accession Number:: 0000711377-10-000039
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2010-10-12 17:20:24
Reporting Period:: 2010-10-07

Filing Date:: 2010-10-12
Accepted Time:: 2010-10-12 17:20:24
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
711377	Neogen Corp	NEOG	In Vitro & In Vivo Diagnostic Substances (2835)	382367843

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1188979	C Jack Parnell			Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2010-10-07	649	$34.04	31,019	No	4	S	Direct
Common Stock	Disposition	2010-10-08	1,983	$34.67	29,036	No	4	S	Direct
Common Stock	Disposition	2010-10-11	1,451	$34.00	27,585	No	4	S	Direct
Common Stock	Disposition	2010-10-12	3,000	$34.63	24,585	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Common Stock Option (Right to buy)	Acquisiton	2010-10-07	2,000	$0.00	2,000	$33.63

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2020-10-07	No	4	A	Direct

Footnotes

The stock option was granted 10/7/10 as a Non-Qualified option and will become exercisable 33% yearly.